Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Mu Opioid Receptor 1 Antibodies:
anti-Human Mu Opioid Receptor 1 Antibodies:
anti-Mouse (Murine) Mu Opioid Receptor 1 Antibodies:
Go to our pre-filtered search.
Bird (Sturnidae) Polyclonal Mu Opioid Receptor 1 Primary Antibody for IEM, ICC - ABIN617908
Gracy, Svingos, Pickel: Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. in The Journal of neuroscience : the official journal of the Society for Neuroscience 1997
Show all 125 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for IHC - ABIN966719
Wang, Johnson, Persico, Hawkins, Griffin, Uhl: Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. in FEBS letters 1994
Show all 7 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for IF, IHC - ABIN437976
Nassirpour, Bahima, Lalive, Lüscher, Luján, Slesinger: Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2010
Show all 2 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for IF (p), IHC (p) - ABIN701755
Laureano, Dalle Molle, Alves, Luft, Desai, Ross, Silveira: Intrauterine growth restriction modifies the hedonic response to sweet taste in newborn pups - Role of the accumbal μ-opioid receptors. in Neuroscience 2016
Show all 2 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for IHC, IHC (p) - ABIN441215
Dever, Xu, Fitting, Knapp, Hauser: Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. in Journal of neurovirology 2012
Show all 2 Pubmed References
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for IF (p), IHC (p) - ABIN703210
Brewer, Baran, Whitfield, Jensen, Clemens: Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord. in Frontiers in neural circuits 2014
Show all 2 Pubmed References
Polyclonal Mu Opioid Receptor 1 Primary Antibody for WB - ABIN4948303
Rodríguez-Muñoz, de la Torre-Madrid, Gaitán, Sánchez-Blázquez, Garzón: RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. in Cellular signalling 2007
Human Polyclonal Mu Opioid Receptor 1 Primary Antibody for ICC, IHC (fro) - ABIN250447
Vassoler, Wright, Byrnes: Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring. in Neuropharmacology 2016
MicroRNA miR (show MYLIP Antibodies)-212/132 cluster is actively repressing the expression of mu opioid receptor (Oprm1) by targeting a sequence in the 3' UTR (show UTS2R Antibodies) of its mRNA.
demonstrate that zfMOR exhibits a pharmacological profile similar to that of the mammalian MOR.
that promoter fragments of OPRK1 (show OPRK1 Antibodies) and OPRM1 were able to upregulate gene expression with mild cognitive impairment
Low OPRM1 expression is associated with L-asparaginase (show ASRGL1 Antibodies) resistance in pediatric acute lymphoblastic leukemia.
PET imaging with [11C]carfentanil tested the hypotheses that acute cigarette smoking increases release of endogenous opioids in the human brain and that smokers have an upregulation of mu opioid receptors (MORs) when compared to nonsmokers. No significant changes found in binding potential of [11C]carfentanil between the placebo and active cigarette sessions; no differences in MOR binding between smokers and nonsmokers.
These results do not support strong modulatory effects of OPRM1 genetic variation on opioid receptor antagonist attenuation of alcohol- and food-related behaviors.
AG and GG genotypes of OPRM1 rs1799971 were associated with a decreased risk of CVS ( P <0.05). In addition, AG and GG genotypes of OPRM1 rs1799971 were correlated with migraine episodes and a family history of migraines.
Subjects with schizophrenia who had the OPRM1 *G genotype smoked more cigarettes per day than the AA allele carriers with schizophrenia. In bipolar patients, there were no OPRM1 genotype differences in smoking status.
The MOR-Gal1R (show GALR1 Antibodies) heteromer can explain previous results showing antagonistic galanin (show GAL Antibodies)-opioid interactions and offers a new therapeutic target for the treatment of opioid use disorder
This study examined associations of the mu opioid receptor gene with several self-report measures relating to personality. These analyses revealed a pattern of Gene x Environment interactions that are consistent with the view that the G allele confers greater vulnerability than the A allele to adverse effects of childhood social adversity on adult personality qualities related to social connection.
MOR is present in human endometrium and levels change during the menstrual cycle.
Data show the multimicrosecond, all-atom molecular dynamics (MD) simulations of the binding of oliceridine (TRV-130) to the activated mu-opioid receptor (MOR) crystal structure.
Findings implicate truncated Oprm1 6TM splice variants in analgesic mechanisms and suggest that they may help explain many of the subtle, but important, clinical differences among mu opioids.
The data show that somatic MORs in POMC (show POMC Antibodies) neurons couple to multiple effectors that have differential sensitivity to desensitization of the receptor.
C termini generated from 3' alternative splicing of the mu opioid receptor gene are pharmacologically distinct.
Double mothering normalized the abnormal response to maternal separation in Oprm1-knockout mice, in an animal model of Autism.
OPRM1, expressed by primary afferent nociceptors, initiates opiate tolerance and opioid-induced hyperalgesia development.
Study reveals dissociable Mu opioid receptors (MOR) functions across mesocorticolimbic networks. Beyond a role in reward processing, operating at the level of local ventral tegmental area neurons, MORs also moderate motivation for appetitive stimuli within forebrain circuits that drive motivated behaviors.
MOR-T394 mutation or polymorphisms could be a risk factor in developing opioid abuse and addiction and therefore be used as a new biomarker in prediction and prevention of opioid abuse and addiction
MOR epigenetic regulation requires multiple coordinated signals converging at the MOR promoter, involving mitogen-activated protein kinase (show MAPK1 Antibodies) (MAPK (show MAPK1 Antibodies)) activation and mitogen- and stress-activated protein kinase 1 (show RPS6KA5 Antibodies).
inhibition of mu-opioid receptor expression blocks morphine and DAMGO increases in the translocation of NF-kB p65 protein in microglia.a low dose of morphine, exerting its effects via the mu-opioid receptor, increases the DNA-binding activity of NF-kB via PKCepsilon, while a high dose of morphine triggers a nonopiate receptor response mediated by TLR4 and, interestingly, PKC signalling
Paternally expressed 11/Retrotransposon-like 1 (Peg11/Rtl1 (show RTL1 Antibodies)) knockout (KO) mice show mid- to late fetal lethality or late fetal growth retardation associated with frequent neonatal lethality
Coactivation of mu opioid receptors with nociceptin (show PNOC Antibodies) receptors produces synergistic antinociception.
Thisstudy adds to the growing literature showing that variation in the mu-opioid receptor gene OPRM1 is associated with social attachment and rejection.
OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors.
findings suggest a role for OPRM1 variation in the expression of attachment behavior, especially as a function of separation from the caregiver
This gene encodes one of three opioid receptors. The mu opioid receptor is the principal target of endogenous opioid peptides and opioid analgesic agents such a s beta-endorphn and enkephalins. The NM_001008503.1:c.118A>G allele had been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene.
, mu-type opioid receptor
, opioid receptor, mu 1
, mu-opioid receptor
, outer membrane efflux protein
, outer membrane protein OprM
, malate dehydrogenase, mitochondrial
, mu opioid receptor splice variant rMOR-1S
, mu opioid receptor splice variant rMOR-1Z
, opioid receptor B
, micro opioid receptor isoform hMOR-1A2
, mu opiate receptor
, mu opioid receptor hMOR-1a
, MOP receptor
, mu opioid receptor
, mammalian retrotransposon derived protein 1
, paternally expressed gene 11 protein
, retrotransposon-derived protein PEG11
, retrotransposon-like protein 1